| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/2003 | EP0850070B1 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 01/22/2003 | EP0844241B1 Inhibitor for narcotic analgetic dependence/resistance acquisition |
| 01/22/2003 | EP0842180B1 Penam sulfones as beta-lactamase inhibitors |
| 01/22/2003 | EP0831777B1 Dinucleotides useful for the treatment of lung disease |
| 01/22/2003 | EP0828728B1 Phenyl dihydrobenzofuranes |
| 01/22/2003 | EP0775115B1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof |
| 01/22/2003 | EP0729465B1 Pyrone derivatives as protease inhibitors and antiviral agents |
| 01/22/2003 | EP0728009B1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier |
| 01/22/2003 | EP0646115B1 Heterocyclic-cyclic amine derivatives |
| 01/22/2003 | CN1392875A Condensed azepines as vasopressino agonists |
| 01/22/2003 | CN1392874A Cyclic amidine compounds |
| 01/22/2003 | CN1392796A Polyhydroxylated benzene-containing compounds |
| 01/22/2003 | CN1392795A Novel tiotropiumonium-containing inhalation powder |
| 01/22/2003 | CN1392167A Preparing process and use of ginkgo leaf polypentenol and ginkgo leaf extract |
| 01/22/2003 | CN1392154A Antisense nucleic acid with virus infection inhibiting function |
| 01/22/2003 | CN1392146A Water cress extract and its preparing method and use |
| 01/22/2003 | CN1392137A New cyclic alpha-amino-gamma hydroxy amide compound, its preparing method and medicinal composition containing said compound |
| 01/22/2003 | CN1391952A Medicine for curing pain syndrome of late cancer and its preparation |
| 01/22/2003 | CN1391951A Burn paste and its preparing method |
| 01/22/2003 | CN1391942A New medicine for anti-cancer, anti-AIDs and giving-up drug habits and its preparing and applying method |
| 01/22/2003 | CN1391939A External medicine for curing traumatic injuries |
| 01/22/2003 | CN1391933A Medicinal composition for improving memory |
| 01/22/2003 | CN1391930A External medicine for curing gynaecological imflammation and its preparing method |
| 01/22/2003 | CN1391928A Medicine Qingyedan for curing hepatitis and its preparing method |
| 01/22/2003 | CN1391908A External applied paste as antidiarrheal |
| 01/22/2003 | CN1391904A Nano hydroxy apatite calcium supplementing agent |
| 01/22/2003 | CN1391901A Injection for curing hemangioma |
| 01/22/2003 | CN1391900A Microcapsule coated liposoluble vitamin product and its producing method |
| 01/22/2003 | CN1391899A Aseptic freeze-dried prostaglandin injection and its preparing method and use |
| 01/22/2003 | CN1391898A Water soluble vitamin product coated with micro capsule and its producing method |
| 01/22/2003 | CN1391897A Flunarizine hydro-chloride capsule pill |
| 01/22/2003 | CN1391896A Quinoline keto derivatives medicinal composition and its preparing method |
| 01/22/2003 | CN1391895A New oral dosage form of Anethol Trithione |
| 01/22/2003 | CN1391894A Silybin injection containing cyclo dextrin or its derivatives |
| 01/22/2003 | CN1391893A Process for preparing simvastation drip pill |
| 01/22/2003 | CN1391892A Total gambogic acid preparation and its preparing method |
| 01/22/2003 | CN1391891A Taxol hidden liposome |
| 01/22/2003 | CN1391890A Oral melbine hydrocloride slow-releasing prepn and its preparing method |
| 01/22/2003 | CN1391889A Tanshinone nano preparation and its preparing method |
| 01/22/2003 | CN1099605C Ophthalmic lens with anti-toxic agent |
| 01/22/2003 | CN1099462C Medical composition |
| 01/22/2003 | CN1099425C 新的肽衍生物 New peptide derivatives |
| 01/22/2003 | CN1099419C Azebicyclic compound |
| 01/22/2003 | CN1099417C New polycyclic 2,3-phthalazine derivatives and their use |
| 01/22/2003 | CN1099416C Integrin receptor antagonisis |
| 01/22/2003 | CN1099413C Certain fused N-pyrrolylaniline: new class of GABA brain receptor ligand |
| 01/22/2003 | CN1099407C Novel amino acid derivatives with improved multi-drug resistance activity |
| 01/22/2003 | CN1099403C Novel ether compound and its preparing method |
| 01/22/2003 | CN1099291C Traditional Chinese medicine preparation for treating nasal meatus disease |
| 01/22/2003 | CN1099287C Medicinal composition and its use |
| 01/22/2003 | CN1099286C Use of forskolin in manufacture of medicament for treatment of alcohol addiction |
| 01/22/2003 | CN1099285C Novel anti-spasmodic and anti-inflammatory agent composition and its process for manufacturing |
| 01/22/2003 | CN1099284C Aryloxy propyl amine compound for treatment of incontinence of urine |
| 01/22/2003 | CN1099276C Medical probe with stylets |
| 01/21/2003 | US6509499 Nervous system disorders, vision defects, diabetic retinopathy, neuropathic pain and kidney disorder treatment |
| 01/21/2003 | US6509492 Pseudoephedrine, chlorpheniramine, and/or dextromethorphan tannates; antitussives, decongestants, antiallergens; influenza, rhinitis; respiratory system and viral disease treatment; single dose liquid suspension |
| 01/21/2003 | US6509483 Method for the preparation of citalopram |
| 01/21/2003 | US6509480 4,7,8 alpha H-eudesma-5(6), 11(13)-dien-8, 12-olide derivatives |
| 01/21/2003 | US6509476 Process for preparing N-benzyl indoles |
| 01/21/2003 | US6509468 FR 173657 used as an antiallergen, antiinflammatory agent, antishock agent, or analgesic; autoimmune diseases |
| 01/21/2003 | US6509464 1-Heteroaryl-pyrrolidine, piperidine, or homopiperidine derivates; nervous system disorder treatment; amidation |
| 01/21/2003 | US6509380 A method of controlling iron overload in a mammal in need thereof, comprising: administering to said mammal an effective amount of acetaminophen for controlling iron overload in said mammal. |
| 01/21/2003 | US6509378 Acetamidobenzamide compounds for neurodegenerative disorders |
| 01/21/2003 | US6509377 A method for inhibiting the activation of transcription factor NF- kappa B in a warm-blooded animal in need thereof, comprises administering to said animal an effective amount of a compound of formula I hydroxy-4-trifluoromethylbenzoic acid |
| 01/21/2003 | US6509376 Utilization of dialkyfumarates |
| 01/21/2003 | US6509375 Method for increasing productivity in breeder hens |
| 01/21/2003 | US6509372 Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin |
| 01/21/2003 | US6509371 Compositions containing Bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 01/21/2003 | US6509370 Paclitaxel formulation |
| 01/21/2003 | US6509369 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 01/21/2003 | US6509368 Use of catechol derivatives as proteinase inhibitors |
| 01/21/2003 | US6509367 Pyrazole cannabinoid agonist and antagonists |
| 01/21/2003 | US6509365 Useful as inhibitors of poly(ADP-ribose)polymerase and for the production of drugs. |
| 01/21/2003 | US6509364 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2α antagonists |
| 01/21/2003 | US6509363 P38 is a mitogen-activated protein kinase; pyrrole, oxazole, thiazole, and imidazole derivatives |
| 01/21/2003 | US6509362 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
| 01/21/2003 | US6509357 1-aryl or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/21/2003 | US6509356 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity |
| 01/21/2003 | US6509355 Treatment of disorders of the outer retina |
| 01/21/2003 | US6509354 3-arylphenyl sulfide derivative and insecticide and miticide |
| 01/21/2003 | US6509353 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 01/21/2003 | US6509351 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation |
| 01/21/2003 | US6509349 Antimicrobial 2-pyridones, their compositions and uses |
| 01/21/2003 | US6509348 Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination |
| 01/21/2003 | US6509346 Chemokine receptor antagonists and methods of use therefor |
| 01/21/2003 | US6509345 For therapy of cancerous diseases |
| 01/21/2003 | US6509344 Indenoisoquinolines as antineoplastic agents |
| 01/21/2003 | US6509341 The invention relates to carboxylic acid derivatives of formula (I), wherein the substituents have the meaning as commented in the description. It also relates to the production and use of same as endothelin receptor antagonists. |
| 01/21/2003 | US6509340 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligands |
| 01/21/2003 | US6509339 Gastrointestinal disorders; cardiovascular disorders |
| 01/21/2003 | US6509337 A method of treating a mammalian disease condition mediated by metalloproteinase activity which comprises administering to a mammal in need thereof a therapeutically effective amount of a compound as defined in claim 1 or a pharmaceutically |
| 01/21/2003 | US6509335 This invention discloses benzoxazinone and benzothiazinone compounds which display inhibitory effects on serine proteases such as factor Xa, thrombin, and/or factor VIIa. The invention also discloses pharmaceutically acceptable salts of |
| 01/21/2003 | US6509334 Cyclocarbamate derivatives as progesterone receptor modulators |
| 01/21/2003 | US6509333 1-(3-methyl-1-(1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4 -benzodiazepin-3-ylcarbamoyl)-butyl)-cyclopent-3-enecarboxylic amide, for example; gamma-secretase inhibitors; Alzhemier's disease, Down's Syndrome |
| 01/21/2003 | US6509332 Methods of treating excessive intraocular pressure |
| 01/21/2003 | US6509331 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2003 | US6509329 Cyclic diamine compound with 6-membered ring groups |
| 01/21/2003 | US6509328 Glutamate receptor antagonists |
| 01/21/2003 | US6509327 Instilling a therapeutically effective amount of a quinoline antibiotic composition in the affected ear to eradicate pathogenic Microbacterium species |
| 01/21/2003 | US6509326 Supplements are useful for increasing bone growth and treating age-related bone loss |